Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine
Highlights ► Pentavac® vaccine demonstrated an excellent and long-lasting immune response. ► Quadrovax® vaccine induces good anamnestic response to all vaccine components. ► Quadrovax vaccine was well tolerated by all vaccinees. ► No serious adverse event was reported in either group. ► Pentavac is...
Gespeichert in:
Veröffentlicht in: | Vaccine 2013-01, Vol.31 (3), p.444-447 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights ► Pentavac® vaccine demonstrated an excellent and long-lasting immune response. ► Quadrovax® vaccine induces good anamnestic response to all vaccine components. ► Quadrovax vaccine was well tolerated by all vaccinees. ► No serious adverse event was reported in either group. ► Pentavac is inexpensive and is a good alternative to other costlier similar vaccines. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2012.11.038 |